Scleroderma Apex: Mapping the Path to Effective Therapy in Systemic Sclerosis

Designed specifically for pharmaceutical and biotech colleagues, Scleroderma Apex provides a platform to share knowledge and innovations from global experts in the field of scleroderma. The purpose of the program includes the following:

• Updates and understanding of the pathogenesis of systemic sclerosis and related interstitial lung disease;
• Clinical trials and regulatory aspects, potential challenges in trial design, and ways to overcome them;
• Critical overview of lessons learned from recent scleroderma trials.

The schedule is set to Pacific Standard Time.